# Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

Study · id `cardio:ct-nct02247128` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02247128](<https://clinicaltrials.gov/study/NCT02247128>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02247128

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Valve and congenital heart disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1016 participants.

## Technical summary

Registry record NCT02247128. Randomized; no masking; primary purpose prevention. Start 2014-01 (registry gives no type); primary completion 2020-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1016 participants (enrolled count; ClinicalTrials.gov record NCT02247128, source copy `cardio:ctgov-nct02247128-2020-04-30`, retrieved 2026-10-26)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT02247128, source copy `cardio:ctgov-nct02247128-2020-04-30`, retrieved 2026-10-26)
- Primary completion: 2020-03 (actual) (ClinicalTrials.gov record NCT02247128, source copy `cardio:ctgov-nct02247128-2020-04-30`, retrieved 2026-10-26)
- Completion: 2020-04 (actual) (ClinicalTrials.gov record NCT02247128, source copy `cardio:ctgov-nct02247128-2020-04-30`, retrieved 2026-10-26)
- Countries: Belgium; Czechia; Luxembourg; Netherlands (ClinicalTrials.gov record NCT02247128, source copy `cardio:ctgov-nct02247128-2020-04-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02247128-2020-04-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
- Acronym: POPular-TAVI
- Condition: Aortic Valve Disease
- Condition: Myocardial Infarction
- Condition: Stroke
- Condition: Bleeding
- Intervention (Drug): Aspirin + clopidogrel
- Intervention (Drug): Aspirin monotherapy
- Intervention (Drug): OAC + clopicogrel
- Intervention (Drug): OAC monotherapy
- Lead sponsor: St. Antonius Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: St. Antonius Hospital (`cardio:org-st-antonius-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation (`cardio:pubmed-32223116`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation (`cardio:pubmed-32865376`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: dcb9577cda8fd6a8aa85ea37611302940cdc39bbbed41fdc403cf0e04cdd4276
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
